Barclays analyst Michael Leithead lowered the firm’s price target on DuPont to $70 from $72 and keeps an Equal Weight rating on the shares. Demand “remains tepid” for U.S. chemicals into the Q2 prints and hopes for a second half of the year recovery “have dimmed,” the analyst tells investors in a research note. While demand “seems to be at trough,” the firm does not think earnings revisions “are quite there yet.” Barclays is not in the camp to “buy the last cut” and continues to pick its spots, with tactical caution across the space into earnings.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on DD:
- DuPont volumes to inflect higher in second half of 2023, says RBC Capital
- DuPont Announces Regular Quarterly Dividend on Common Stock
- DuPont, JetCool announce collaboration in thermal management
- DuPont de Nemours put volume heavy and directionally bearish
- Citi starts coverage of North America Chemicals with 7 Buys, 8 Neutrals